Deutsche Bank Says Pfizer (PFE) and Allergan (AGN) Deal Would Enhance Cash Access
Deutsche Bank maintained a Buy rating on Pfizer (NYSE: PFE) with a price target of $43. Comments follow rumors related ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
